169 related articles for article (PubMed ID: 22009326)
1. BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain.
Sillars-Hardebol AH; Carvalho B; Beliën JA; de Wit M; Delis-van Diemen PM; Tijssen M; van de Wiel MA; Pontén F; Fijneman RJ; Meijer GA
J Pathol; 2012 Feb; 226(3):442-50. PubMed ID: 22009326
[TBL] [Abstract][Full Text] [Related]
2. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA
Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630
[TBL] [Abstract][Full Text] [Related]
3. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression.
Carvalho B; Postma C; Mongera S; Hopmans E; Diskin S; van de Wiel MA; van Criekinge W; Thas O; Matthäi A; Cuesta MA; Terhaar Sive Droste JS; Craanen M; Schröck E; Ylstra B; Meijer GA
Gut; 2009 Jan; 58(1):79-89. PubMed ID: 18829976
[TBL] [Abstract][Full Text] [Related]
4. CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.
Sillars-Hardebol AH; Carvalho B; Beliën JA; de Wit M; Delis-van Diemen PM; Tijssen M; van de Wiel MA; Pontén F; Meijer GA; Fijneman RJ
Cell Oncol (Dordr); 2012 Aug; 35(4):293-300. PubMed ID: 22711543
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal instability in flat adenomas and carcinomas of the colon.
Postma C; Hermsen MA; Coffa J; Baak JP; Mueller JD; Mueller E; Bethke B; Schouten JP; Stolte M; Meijer GA
J Pathol; 2005 Mar; 205(4):514-21. PubMed ID: 15685687
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression.
de Groen FL; Timmer LM; Menezes RX; Diosdado B; Hooijberg E; Meijer GA; Steenbergen RD; Carvalho B
PLoS One; 2015; 10(7):e0132495. PubMed ID: 26148070
[TBL] [Abstract][Full Text] [Related]
8. Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression.
de Groen FL; Krijgsman O; Tijssen M; Vriend LE; Ylstra B; Hooijberg E; Meijer GA; Steenbergen RD; Carvalho B
Genes Chromosomes Cancer; 2014 Apr; 53(4):339-48. PubMed ID: 24478024
[TBL] [Abstract][Full Text] [Related]
9. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
10. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
Kitamura S; Kondo S; Shinomura Y; Kanayama S; Miyazaki Y; Kiyohara T; Hiraoka S; Matsuzawa Y
Br J Cancer; 2000 Sep; 83(5):668-73. PubMed ID: 10944610
[TBL] [Abstract][Full Text] [Related]
11. Evidence for post-transcriptional down-regulation of the apoptosis-related gene bcl-2 in human colorectal cancer.
Berney CR; Downing SR; Yang JL; Russell PJ; Crowe PJ
J Pathol; 2000 May; 191(1):15-20. PubMed ID: 10767713
[TBL] [Abstract][Full Text] [Related]
12. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
Chell SD; Witherden IR; Dobson RR; Moorghen M; Herman AA; Qualtrough D; Williams AC; Paraskeva C
Cancer Res; 2006 Mar; 66(6):3106-13. PubMed ID: 16540660
[TBL] [Abstract][Full Text] [Related]
13. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
de Wit M; Jimenez CR; Carvalho B; Belien JA; Delis-van Diemen PM; Mongera S; Piersma SR; Vikas M; Navani S; Pontén F; Meijer GA; Fijneman RJ
Gut; 2012 Jun; 61(6):855-64. PubMed ID: 21890811
[TBL] [Abstract][Full Text] [Related]
14. Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL.
Nguyen HT; Geens M; Mertzanidou A; Jacobs K; Heirman C; Breckpot K; Spits C
Mol Hum Reprod; 2014 Feb; 20(2):168-77. PubMed ID: 24217388
[TBL] [Abstract][Full Text] [Related]
15. Dominant genetic alterations in immortalization: role for 20q gain.
Cuthill S; Agarwal P; Sarkar S; Savelieva E; Reznikoff CA
Genes Chromosomes Cancer; 1999 Dec; 26(4):304-11. PubMed ID: 10534765
[TBL] [Abstract][Full Text] [Related]
16. Congenital genetic instability in colorectal carcinomas.
Svendsen LB
Dan Med Bull; 1993 Nov; 40(5):546-56. PubMed ID: 8299399
[TBL] [Abstract][Full Text] [Related]
17. Relationship of gene expression and chromosomal abnormalities in colorectal cancer.
Tsafrir D; Bacolod M; Selvanayagam Z; Tsafrir I; Shia J; Zeng Z; Liu H; Krier C; Stengel RF; Barany F; Gerald WL; Paty PB; Domany E; Notterman DA
Cancer Res; 2006 Feb; 66(4):2129-37. PubMed ID: 16489013
[TBL] [Abstract][Full Text] [Related]
18. IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence.
Cui G; Yuan A; Goll R; Florholmen J
Scand J Gastroenterol; 2012 Nov; 47(11):1304-12. PubMed ID: 22989213
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.
Cao J; Li W; Xie J; Du H; Tang W; Wang H; Chen X; Xiao W; Li Y
Surg Oncol; 2006 Dec; 15(4):223-33. PubMed ID: 17382535
[TBL] [Abstract][Full Text] [Related]
20. Loss of 1p36, gain of 8q24, and loss of 9q34 are associated with stroma percentage of colorectal cancer.
Fijneman RJ; Carvalho B; Postma C; Mongera S; van Hinsbergh VW; Meijer GA
Cancer Lett; 2007 Dec; 258(2):223-9. PubMed ID: 17977645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
